The market size of the Global bowel management systems market in 2021 is valued at 2.07 billion and is predicted to reach 2.87 billion by the year 2030 at an 3.83% CAGR during the forecast period.
Bowel management systems control the containment of liquid or semi-liquid stools. It is applied to people with fecal incontinence to protect their skin from pollutants and moisture that could lead to skin damage. Containing infected body waste in a closed system decreases the spread of infection. Furthermore, it offers protection by supporting the sacral and perianal pressure points. The chance of unintentional stool leakage and constipation can be greatly reduced by using bowel management systems or devices such as colostomy bags, irrigation systems, and others. Due mainly to the availability of technologically cutting-edge bowel management devices, the market for bowel management systems is anticipated to rise significantly throughout the forecast period. Additionally, the market is growing due to the ageing population and an increase in diseases like irritable bowel syndrome linked to fecal irregularity. Irritable bowel syndrome incidence has markedly increased in recent years, with reports from around the world. For instance, the American College of Gastroenterology estimates that between 10% and 15% of adults in the U.S. experience symptoms of IBS.
However, a surge in government R&D expenditures in the healthcare industry fuels the market for bowel management systems. The market isn't growing, though, because there aren't enough qualified specialists and patients find these gadgets uncomfortable to use. Contrarily, it is anticipated that developing healthcare R&D facilities and introducing numerous new devices would open up lucrative chances to expand the bowel management system market.
Market Segmentation:
The bowel management systems market is segmented by product, patient type and end user. Based on the product, the market is segmented into systems (colostomy bags, irrigation systems, sacral neuromodulation systems and others) and accessories (plugs, catheters, implants, anal sphincters, stool bags and others). Based on the patient type, the market is segmented into adult and pediatric. Based on the end user, the market is segmented into hospitals, ambulatory surgical centres and home care settings.
Based on the product, the system category is accounted as a major contributor to the bowel management systems market.
The system category dominated the market in 2021 because more complex bowel management methods are being approved. For instance, in 2020, the U.S. FDA approved Medtronic's InterStim Micro neurostimulator, and InterStim SureScan MRI leads to treating bladder and bowel control issues. Colostomy bags, a subsection of the system category, have a more significant share than the others; nevertheless, people are becoming more aware of their availability and advantages. Additionally, it is predicted that the market will grow throughout the projection period due to developed regions having well-organized reimbursement systems for colostomy goods. However, government entities in developed areas are introducing programs to support people with stomas by enhancing access to the most suitable and therapeutically relevant stoma-related products.
The adult category witnessed growth at a rapid rate.
The adult category dominated the market in 2021 because adult people are more likely to experience fecal irregularity problems. Additionally, elderly persons require additional aid and consideration when managing consistency. Therefore, increasing the world's older population supports the market's expansion. It affects roughly 1 in 12 adults, or 18 million people, in the United States, making it a common illness among adults.
The North American bowel management systems market holds a signification revenue share.
The North American bowel management systems market is expected to register the highest market share. The considerable rise in the number of older adults in this area accounts for this. The dominance of the United States in the North American market is expected to remain constant over the projection period. Irritable bowel syndrome is more common in this area, which is the cause of this. For instance, the International Foundation for Gastrointestinal Disorders estimates that 25 and 45 million Americans suffer from IBS. Additionally, a key trend in the North American market for bowel management systems is ongoing R&D for creating cutting-edge bowel management devices for fecal management. The increase in older adults in this area also helps the industry flourish. In addition, Asia Pacific is projected to grow rapidly in the global bowel management systems market due to rising healthcare infrastructure demand, an increase in hospitals in developing nations, rapid R&D sector expansion, a rise in healthcare reforms, and technical developments in the industry. Additionally, the market is expected to be driven by the enormous unmet clinical needs and the urgent need for better therapy.
Competitive Landscape
Key players in the bowel management systems market are Axonics Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Coloplast Group, ConvaTec Group, plc, Consure Medical, Hollister Incorporated, Laborie Medical Technologies, Corp., ProSys International Ltd., Renew Medical, Inc., Welland Medical Limited, Qufora A/S, Medtronic, Wellspect HealthCare and TG Eakin.
By Patient Type-
